Skip to main content
Equibles

TITANBIO · TITAN BIOTECH LTD. · Investor Relations

Use TITANBIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TITANBIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
366.65 INR -4.35 (-1.17%) At close · Nov 13
Rebalance outlook locked
Market Cap
18.94B INR
Shares
51.65M
Volume · Nov 13 36.71K Avg daily vol (16 sessions) 43.6K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-10-31 Consideration of Unaudited Financial Results for the quarter ended on September 30, 2026 Event
2026-08-05 Consideration of Unaudited Financial Results for the quarter ended on June 30, 2026 Event
2026-05-20 Consideration of Audited Financial Results for the year ended on March 31, 2026 and dividend Event
2026-02-03 Consideration of Unaudited Financial Results for the Quarter ended on December 31, 2025 Event
2025-11-04 Consideration of Unaudited Financial Results for the Quarter ended on September 30, 2025 Event
2025-08-01 Consideration of Unaudited Financial Results for the Quarter ended on June 30, 2025 Event
2025-05-26 Consideration of audited Financial Results (Q4) and dividend for the Financial year ended on March 31, 2025 Event
2025-01-03 Consideration of Unaudited Financial Results for the Quarter ended on December 31, 2024 Event
2024-11-05 Consideration of Unaudited Financial Results for the Quarter ended on September 30, 2024 Event
2024-08-03 Consideration of Unaudited Financial Results for the Quarter ended on June 30, 2024 Event
2024-01-30 Consideration of Unaudited Financial Results for the Quarter ended on December 31, 2023 Event
2023-10-26 Consideration of Unaudited Financial Results for the Quarter ended on September 30, 2023 Event
2023-07-31 BSE_BM Intimation for Quarterly Financial Result_June 2023_TBL Event
2023-05-15 Consideration of Audited Financial Results for the year ended on March 31, 2023 and dividend Event
2023-01-27 Consideration of Unaudited Financial Results for the Quarter ended on December 31, 2022 Event
2022-11-04 Consideration of Unaudited Financial Results for the Quarter ended on September 30, 2022 Event
2022-08-02 Consideration of Unaudited Financial Results for the Quarter ended on June 30, 2022 Event
2022-05-19 Consideration of Audited Financial Results for the year ended on March 31, 2022 and dividend Event
2022-01-31 Consideration of Unaudited Financial Results for the Quarter ended on December 31, 2021 Event
2021-11-01 Consideration of Unaudited Financial Results for the Quarter ended on September 30, 2021 Event
2021-08-17 For scheduling 29th AGM and other related matters Event
2021-07-30 Consideration of Unaudited Financial Results for the Quarter ended on June 30, 2021 Event
2021-06-21 Consideration of Audited Financial Results for the year ended on March 31, 2021 and dividend Event
2021-01-18 Consideration of Unaudited Financial Results for the Quarter ended on December 31, 2020 Event
2020-10-08 Consideration of Unaudited Financial Results for the Quarter ended on September 30, 2020 Event

Source: https://titanbiotechltd.com/investor/